Last update:

Oncology & Cancer news

Oncology & Cancer

Most liver cancer cases are due to preventable risk factors, analysis suggests

The majority of liver cancer cases could be prevented by reducing levels of viral hepatitis, alcohol consumption and MASLD (metabolic dysfunction-associated steatotic liver disease—previously called non-alcoholic fatty ...

Oncology & Cancer

Study offers clearer picture of childhood brain tumor survival

Childhood brain tumor survival depends on the type of tumor. Comparing survival rates across countries is difficult, because brain tumors aren't recorded in the same way everywhere in Europe. A new study led by the Princess ...

Oncology & Cancer

Powering up T cells: A new path in cancer immunotherapy

Researchers have discovered a way to make the immune system's T cells significantly more effective at fighting cancer. By blocking a protein called Ant2, they were able to reprogram how these cells consume and generate energy—essentially ...

Oncology & Cancer

Researcher uses light to target and kill cancer cells

A Northeastern University researcher has identified a way to target two of the deadliest cancer types, melanoma and triple negative breast cancer, with chemotherapy drugs but without the harms associated with chemotherapy.

Medical research

New cyclic disulfide lipids help stop cancer growth in mice

Researchers at Nagoya University in Japan have developed a lipid nanoparticle that delivers mRNA to cells five times more effectively. By attaching a sulfur-containing ring structure—a cyclic disulfide—to lipid molecules, ...

Oncology & Cancer

Prostate cancer explained: From antigen tests to treatment options

Prostate cancer is one of the most common cancers in the world. While many prostate cancers grow slowly and remain localized, other types are aggressive and spread quickly. That's why Dr. Carlos Vargas, a Mayo Clinic radiation ...

Oncology & Cancer

Insights into palliative care for patients with cancer

For patients with a cancer diagnosis, early specialty palliative care is considered the standard of care. However, many patients with advanced cancer do not consistently receive specialty palliative care, especially during ...

Oncology & Cancer

Chromatin organization linked to p53 tumor suppression mechanism

Each cell in our bodies carries about two meters of DNA in its nucleus, packed into a tiny volume of just a few hundred cubic micrometers—about a millionth of a milliliter. The cell manages this by winding the strings of ...

Oncology & Cancer

Key enzyme in cell migration and tumor metastasis identified

Konstanz researchers identify an enzyme that plays a role in the migration of cells in our body—not only during normal tissue formation and wound healing, but also when tumor cells metastasize. This makes the enzyme an ...

Oncology & Cancer

Regulatory DNA links cancer and tissue regeneration

A new study published in Life Science Alliance reveals a key genetic connection between cancer susceptibility and tissue regeneration. Researchers at Karolinska Institutet identified a super-enhancer region upstream of the ...

Oncology & Cancer

Blocking an enzyme may improve melanoma immunotherapy outcomes

About 65% of melanoma patients do not respond to immunotherapy. New work by the team of Prof. Max Mazzone (VIB-KU Leuven Center for Cancer Biology) discovered that an enzyme called HPGDS (expressed in a specific subset of ...

Medications

Drug combo offers hope for advanced bladder cancer patients

Urothelium is the term for the mucous membrane that lines the urinary tract. This includes the renal pelvis, ureter, urinary bladder and the upper part of the urethra. In the vast majority of cases, urothelial carcinomas ...

Oncology & Cancer

Getting ahead of head and neck cancer

Many symptoms of head and neck cancer are hard to miss—a lump in the neck, persistent hoarseness, a mouth sore that doesn't heal—which is good news for early detection as long as symptoms aren't dismissed.

Oncology & Cancer

High numbers of rural patients cross state lines for cancer care

In a new study, researchers from Huntsman Cancer Institute at the University of Utah (the U) found that 7% of Medicare patients cross state borders for cancer care, and rates were nearly double for those who lived in rural ...